Company / Current Assets
Valion Bio, Inc. Current Assets History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.6M
FY2024
5-year range
$2.6M / $5.3M
FY2022-FY2024
Trend
-43.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $5M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2024.
Declined from $5M to $3M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current assets decreased 43.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.6M | -43.3% |
| FY2023 | $4.7M | -12.0% |
| FY2022 | $5.3M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026